-

Robbins LLP Reminds Investors that it is Investigating the Acquisition of HRT

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors it is investigating the acquisition of HireRight Holdings Corp. (NYSE: HRT) by investment funds affiliated with General Atlantic, L.P. and Stone Point Capital LLC (the "Sponsors"). Under the terms of the agreement, the Sponsors will acquire all the outstanding shares they do not already own for $14.35 per share in cash.

If you own shares of HireRight Holdings Corp. click here.

Is the Proposed Acquisition Best for HireRight Holdings Corp. (HRT) and its Shareholders?

On February 16, 2024, HireRight announced a deal to be acquired by the Sponsors. According to the Proxy Statement, HireRight's board of directors approved the merger agreement for $14.35 per share in cash. The deal is valued at approximately $1.65 billion and is expected to close mid-2024. Robbins LLP is concerned that HireRight's board of directors engaged in an unfair process and agreed to an unfair amount to be paid to shareholders.

Next Steps: If you own shares of HireRight Holdings Corp. (HRT) you have legal options. Contact us to learn more about your legal rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas, Jr.
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion in value for shareholders. To be notified if a class action against HireRight Holdings Corp. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Place, Suite 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:HRT

Release Summary
Robbins LLP is investigating the acquisition of HireRight Holdings Corp. (HRT)
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Place, Suite 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

UWMC Stockholders Have Rights – If You Lost Money Investing in UWM Holdings Corporation Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired UWM Holdings Corporation (NYSE: UWMC) securities between March 9, 2026 and August 5, 2026 (the "Class Period"). UWM engages in the origination, sale, and servicing of residential mortgage loans in the United States.The complaint alleges that UWM over-hedged itself in anticipation of its acquisition of Two Har...

DLVT Investors Have Rights – If You Lost Money Investing in Datavault AI Inc. Contact Robbins LLP for Information About Recovering Your Losses  

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Datavault AI Inc. (NASDAQ: DVLT) securities between September 4, 2024 and October 30, 2025. Datavault AI is a data sciences technology company, owns and operates data management platforms with high computing capabilities in North America, Asia Pacific, Europe, and internationally. Datavault was previously k...

Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the "Class Period"). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity.The complaint alleges that Fractyl Health misled investors regarding t...
Back to Newsroom